<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.0//EN" "http://www.w3.org/TR/2001/REC-SVG-20010904/DTD/svg10.dtd">
<svg width="2400" height="2400" xmlns="http://www.w3.org/2000/svg" style="background-color:black">
<circle cx="1200" cy="1200" r="1052" style="fill:grey;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="1028" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="1026" style="fill:gainsboro;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="175" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<circle cx="1200" cy="1200" r="173" style="fill:grey;stroke:black;stroke-width:0;fill-opacity:0.085;"/>
<circle cx="1200" cy="1200" r="161" style="fill:black;stroke:black;stroke-width:0;fill-opacity:1;"/>
<text font-size="4.0em" x="50" y="60" fill="white">SARS-CoV-2 mutations 2021 timemap</text>
<text font-size="2.8em" x="50" y="105" fill="white">Genbank MN908947 vs 4,663 GISAID genomes</text>
<line x1="1200" y1="83.1314031180401" x2="1200" y2="133.13140311804" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="1176" y="73.1314031180401" fill="white">Winter</text>
<line x1="2267" y1="1200" x2="2317" y2="1200" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="2267" y="1245" fill="white">Spring</text>
<line x1="1200" y1="2267" x2="1200" y2="2317" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="1045" y="2352" fill="white">Summer</text>
<line x1="133" y1="1200" x2="73" y2="1200" style="stroke:white;stroke-width:4" />
<text font-size="3.0em" x="59" y="1185" fill="white">Fall</text>
<g>	<title>orf1ab gene (21500-21555)</title>
	<line x1="1208" y1="1039" x2="1208" y2="1027" style="stroke:grey;stroke-width:8" />
</g><g>	<title>S gene (21563-25384)</title>
	<line x1="1208" y1="1025" x2="1208" y2="174" style="stroke:gainsboro;stroke-width:8" />
</g><g>	<title>ORF3a gene (25393-25500)</title>
	<line x1="1208" y1="172" x2="1208" y2="148" style="stroke:grey;stroke-width:8" />
</g><line x1="1200" y1="148.13140311804" x2="1200" y2="1039" style="stroke:white;stroke-width:3" />
<line x1="1204" y1="148.13140311804" x2="1210" y2="148.13140311804" style="stroke:white;stroke-width:2" />
<line x1="1210" y1="148.13140311804" x2="1215" y2="123.13140311804" style="stroke:white;stroke-width:2" />
<line x1="1204" y1="1039" x2="1210" y2="1039" style="stroke:white;stroke-width:2" />
<line x1="1210" y1="1039" x2="1215" y2="1064" style="stroke:white;stroke-width:2" />
<text font-size="2.0em" x="1215" y="123.13140311804" fill="white">25.5 kb</text>
<text font-size="2.0em" x="1215" y="1084" fill="white">21.5 kb</text>
<text font-size="2.5em" x="75" y="175" fill="white">Continents</text>
<circle cx="60" cy="205" r="8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="215" fill="white">Europe</text>
<circle cx="60" cy="235" r="8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="245" fill="white">North America</text>
<circle cx="60" cy="265" r="8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="275" fill="white">Oceania</text>
<circle cx="60" cy="295" r="8" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="305" fill="white">Asia</text>
<circle cx="60" cy="325" r="8" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="335" fill="white">Africa</text>
<circle cx="60" cy="355" r="8" style="fill:lime;stroke:black;stroke-width:0;fill-opacity:0.6;" />
<text font-size="2.0em" x="75" y="365" fill="white">South America</text>
<circle cx="60.0" cy="410.0" r="1.2" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<circle cx="100.0" cy="410.0" r="4.2" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<circle cx="140.0" cy="410.0" r="8.0" style="fill:white;stroke:lightgrey;stroke-width:0.2;" />
<text font-size="2.0em" x="50" y="455" fill="white">1      10        100% daily</text>
<text font-size="2.0em" x="50" y="485" fill="white">sample fraction</text>
<g>
	<title>2021-01-01 Europe: 61 samples</title>
	<line x1="1200.3" y1="1180.0" x2="1200.5" y2="1171.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-01 North America: 23 samples</title>
	<line x1="1200.5" y1="1171.9" x2="1200.6" y2="1165.7" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-01 Oceania: 11 samples</title>
	<line x1="1200.6" y1="1165.7" x2="1200.7" y2="1160.9" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-01 Asia: 7 samples</title>
	<line x1="1200.7" y1="1160.9" x2="1200.8" y2="1156.8" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-01  C21614T  Europe=21 [34.4%]  surface glycoprotein, L18F</title>
	<circle cx="1203.3" cy="1013.2" r="6.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-01  G21776A  North America=4 [17.4%]  surface glycoprotein, G72R</title>
	<circle cx="1203.9" cy="977.1" r="5.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-01  C21807A  North America=2 [8.7%]  surface glycoprotein, P82H</title>
	<circle cx="1204.0" cy="970.2" r="3.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-01  C21855T  Europe=3 [4.9%]  surface glycoprotein, S98F</title>
	<circle cx="1204.2" cy="959.5" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-01  C22227T  Europe=42 [68.9%]  surface glycoprotein, A222V</title>
	<circle cx="1205.6" cy="876.7" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-01  C22879A  Europe=3 [4.9%]  surface glycoprotein, N439K</title>
	<circle cx="1208.2" cy="731.5" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-01  T22882G  Asia=2 [28.6%]  surface glycoprotein, N440K</title>
	<circle cx="1208.2" cy="730.8" r="5.9" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-01  G22992A  Europe=4 [6.6%]  surface glycoprotein, S477N</title>
	<circle cx="1208.6" cy="706.3" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-01  C22995A  Europe=2 [3.3%]  surface glycoprotein, T478K</title>
	<circle cx="1208.6" cy="705.6" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-01  A23064C  Oceania=3 [27.3%]  surface glycoprotein, N501T</title>
	<circle cx="1208.9" cy="690.3" r="5.8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-01  G23311C  Europe=2 [3.3%]  surface glycoprotein, E583D</title>
	<circle cx="1209.9" cy="635.3" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-01  A23403G  Oceania=11 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1210.2" cy="614.8" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-01  A23403G  Oceania=11 [100.0%] Europe=60 [98.4%]  surface glycoprotein, D614G</title>
	<circle cx="1210.2" cy="614.8" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-01  A23403G  Oceania=11 [100.0%] Europe=60 [98.4%] North America=22 [95.7%]  surface glycoprotein, D614G</title>
	<circle cx="1210.2" cy="614.8" r="7.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-01  A23403G  Asia=6 [85.7%]  surface glycoprotein, D614G</title>
	<circle cx="1210.2" cy="614.8" r="7.8" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-01  C23604A  North America=3 [13.0%]  surface glycoprotein, P681H</title>
	<circle cx="1211.0" cy="570.0" r="4.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-01  C23604A  Europe=3 [4.9%]  surface glycoprotein, P681H</title>
	<circle cx="1211.0" cy="570.0" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-01  A23756G  Europe=2 [3.3%]  surface glycoprotein, T732A</title>
	<circle cx="1211.6" cy="536.2" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-01  C24378T  Europe=2 [3.3%]  surface glycoprotein, S939F</title>
	<circle cx="1214.0" cy="397.7" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02 Europe: 179 samples</title>
	<line x1="1200.7" y1="1180.0" x2="1201.1" y2="1169.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-02 North America: 90 samples</title>
	<line x1="1201.1" y1="1169.9" x2="1201.4" y2="1161.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-02 Oceania: 5 samples</title>
	<line x1="1201.4" y1="1161.1" x2="1201.5" y2="1157.6" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-02  C21575T  Europe=3 [1.7%]  surface glycoprotein, L5F</title>
	<circle cx="1206.2" cy="1021.9" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  C21597T  Europe=3 [1.7%]  surface glycoprotein, S12F</title>
	<circle cx="1206.4" cy="1017.0" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  G21600T  North America=9 [10.0%]  surface glycoprotein, S13I</title>
	<circle cx="1206.4" cy="1016.4" r="4.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  C21614T  Europe=79 [44.1%]  surface glycoprotein, L18F</title>
	<circle cx="1206.5" cy="1013.3" r="6.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  C21855T  Europe=4 [2.2%]  surface glycoprotein, S98F</title>
	<circle cx="1208.4" cy="959.6" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  G21974T  Europe=3 [1.7%]  surface glycoprotein, D138Y</title>
	<circle cx="1209.3" cy="933.1" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  ATTA21993A  Europe=4 [2.2%]  surface glycoprotein, Y145H</title>
	<circle cx="1209.5" cy="928.9" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  G22018T  North America=9 [10.0%]  surface glycoprotein, W152C</title>
	<circle cx="1209.7" cy="923.3" r="4.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  C22079A  North America=2 [2.2%]  surface glycoprotein, Q173K</title>
	<circle cx="1210.1" cy="909.8" r="2.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  G22205C  Europe=3 [1.7%]  surface glycoprotein, D215H</title>
	<circle cx="1211.1" cy="881.7" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  C22227T  Europe=143 [79.9%]  surface glycoprotein, A222V</title>
	<circle cx="1211.3" cy="876.8" r="7.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  C22329T  Europe=4 [2.2%]  surface glycoprotein, S256L</title>
	<circle cx="1212.1" cy="854.1" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  G22346T  Europe=9 [5.0%]  surface glycoprotein, A262S</title>
	<circle cx="1212.2" cy="850.3" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  C22377T  Europe=5 [2.8%]  surface glycoprotein, P272L</title>
	<circle cx="1212.5" cy="843.4" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  C22879A  Europe=2 [1.1%]  surface glycoprotein, N439K</title>
	<circle cx="1216.4" cy="731.7" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  T22896C  Europe=2 [1.1%]  surface glycoprotein, V445A</title>
	<circle cx="1216.5" cy="727.9" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  T22917G  North America=9 [10.0%]  surface glycoprotein, L452R</title>
	<circle cx="1216.6" cy="723.2" r="4.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  G22992A  Europe=10 [5.6%]  surface glycoprotein, S477N</title>
	<circle cx="1217.2" cy="706.5" r="3.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  C22995A  Europe=3 [1.7%]  surface glycoprotein, T478K</title>
	<circle cx="1217.3" cy="705.9" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  A23063T  Europe=4 [2.2%]  surface glycoprotein, N501Y</title>
	<circle cx="1217.8" cy="690.7" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  A23064C  North America=4 [4.4%]  surface glycoprotein, N501T</title>
	<circle cx="1217.8" cy="690.5" r="2.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  C23271A  Europe=4 [2.2%]  surface glycoprotein, A570D</title>
	<circle cx="1219.4" cy="644.4" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  C23271T  Europe=2 [1.1%]  surface glycoprotein, A570V</title>
	<circle cx="1219.4" cy="644.4" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  G23311C  Europe=3 [1.7%]  surface glycoprotein, E583D</title>
	<circle cx="1219.7" cy="635.5" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  A23403G  North America=90 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1220.4" cy="615.1" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  A23403G  North America=90 [100.0%] Oceania=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1220.4" cy="615.1" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  A23403G  North America=90 [100.0%] Oceania=5 [100.0%] Europe=178 [99.4%]  surface glycoprotein, D614G</title>
	<circle cx="1220.4" cy="615.1" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  G23587T  Europe=2 [1.1%]  surface glycoprotein, Q675H</title>
	<circle cx="1221.9" cy="574.1" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  G23593T  North America=5 [5.6%]  surface glycoprotein, Q677H</title>
	<circle cx="1221.9" cy="572.8" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  C23604A  North America=7 [7.8%]  surface glycoprotein, P681H</title>
	<circle cx="1222.0" cy="570.3" r="3.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  C23604A  North America=7 [7.8%] Europe=10 [5.6%]  surface glycoprotein, P681H</title>
	<circle cx="1222.0" cy="570.3" r="3.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  C23709T  Europe=5 [2.8%]  surface glycoprotein, T716I</title>
	<circle cx="1222.8" cy="546.9" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  A23756G  Europe=3 [1.7%]  surface glycoprotein, T732A</title>
	<circle cx="1223.2" cy="536.5" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  G24095T  North America=3 [3.3%]  surface glycoprotein, A845S</title>
	<circle cx="1225.8" cy="461.0" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  C24174T  Europe=2 [1.1%]  surface glycoprotein, A871V</title>
	<circle cx="1226.4" cy="443.4" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  T24506G  Europe=4 [2.2%]  surface glycoprotein, S982A</title>
	<circle cx="1229.0" cy="369.5" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  G24680T  North America=4 [4.4%]  surface glycoprotein, V1040F</title>
	<circle cx="1230.4" cy="330.8" r="2.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  A24774T  Europe=2 [1.1%]  surface glycoprotein, Q1071L</title>
	<circle cx="1231.1" cy="309.9" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  C24789T  Europe=2 [1.1%]  surface glycoprotein, T1076I</title>
	<circle cx="1231.2" cy="306.6" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  G24914C  Europe=4 [2.2%]  surface glycoprotein, D1118H</title>
	<circle cx="1232.2" cy="278.7" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  G25019T  North America=2 [2.2%]  surface glycoprotein, D1153Y</title>
	<circle cx="1233.0" cy="255.4" r="2.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  G25049T  Europe=3 [1.7%]  surface glycoprotein, D1163Y</title>
	<circle cx="1233.2" cy="248.7" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-02  C25460T  Europe=2 [1.1%]  ORF3a protein, A23V</title>
	<circle cx="1236.4" cy="157.2" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03 Europe: 91 samples</title>
	<line x1="1201.0" y1="1180.0" x2="1201.5" y2="1171.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-03 North America: 61 samples</title>
	<line x1="1201.5" y1="1171.2" x2="1201.9" y2="1163.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-03 Oceania: 4 samples</title>
	<line x1="1201.9" y1="1163.1" x2="1202.1" y2="1160.0" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-03  C21575T  Europe=3 [3.3%]  surface glycoprotein, L5F</title>
	<circle cx="1209.3" cy="1022.1" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  G21600T  North America=3 [4.9%]  surface glycoprotein, S13I</title>
	<circle cx="1209.6" cy="1016.5" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  C21614T  Europe=31 [34.1%]  surface glycoprotein, L18F</title>
	<circle cx="1209.8" cy="1013.4" r="6.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  C21621T  North America=3 [4.9%]  surface glycoprotein, T20I</title>
	<circle cx="1209.9" cy="1011.8" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  C21648T  North America=4 [6.6%]  surface glycoprotein, T29I</title>
	<circle cx="1210.2" cy="1005.8" r="3.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  G21850T  Europe=2 [2.2%]  surface glycoprotein, E96D</title>
	<circle cx="1212.5" cy="960.9" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  G22018T  North America=3 [4.9%]  surface glycoprotein, W152C</title>
	<circle cx="1214.5" cy="923.5" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  C22079A  North America=2 [3.3%]  surface glycoprotein, Q173K</title>
	<circle cx="1215.2" cy="910.0" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  C22227T  Europe=74 [81.3%]  surface glycoprotein, A222V</title>
	<circle cx="1216.9" cy="877.1" r="7.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  C22329T  Europe=3 [3.3%]  surface glycoprotein, S256L</title>
	<circle cx="1218.1" cy="854.4" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  G22346T  Europe=9 [9.9%]  surface glycoprotein, A262S</title>
	<circle cx="1218.3" cy="850.6" r="4.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  C22377T  Europe=5 [5.5%]  surface glycoprotein, P272L</title>
	<circle cx="1218.7" cy="843.7" r="3.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  C22879A  Europe=2 [2.2%]  surface glycoprotein, N439K</title>
	<circle cx="1224.5" cy="732.0" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  T22917G  North America=4 [6.6%]  surface glycoprotein, L452R</title>
	<circle cx="1225.0" cy="723.6" r="3.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  G22992A  Europe=2 [2.2%]  surface glycoprotein, S477N</title>
	<circle cx="1225.8" cy="706.9" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  G22992T  Europe=2 [2.2%]  surface glycoprotein, S477I</title>
	<circle cx="1225.8" cy="706.9" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  A23064C  Oceania=2 [50.0%]  surface glycoprotein, N501T</title>
	<circle cx="1226.7" cy="690.9" r="6.8" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  G23120T  North America=2 [3.3%]  surface glycoprotein, A520S</title>
	<circle cx="1227.3" cy="678.4" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  C23277T  North America=4 [6.6%]  surface glycoprotein, T572I</title>
	<circle cx="1229.2" cy="643.5" r="3.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  A23403G  Europe=91 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1230.6" cy="615.5" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  A23403G  Europe=91 [100.0%] North America=61 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1230.6" cy="615.5" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  A23403G  Europe=91 [100.0%] North America=61 [100.0%] Oceania=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1230.6" cy="615.5" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  G23438T  Europe=2 [2.2%]  surface glycoprotein, A626S</title>
	<circle cx="1231.0" cy="607.7" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  G23593T  North America=7 [11.5%]  surface glycoprotein, Q677H</title>
	<circle cx="1232.8" cy="573.2" r="4.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  C23604A  North America=4 [6.6%]  surface glycoprotein, P681H</title>
	<circle cx="1233.0" cy="570.8" r="3.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  C23625T  Europe=2 [2.2%]  surface glycoprotein, A688V</title>
	<circle cx="1233.2" cy="566.1" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  G24368A  North America=4 [6.6%]  surface glycoprotein, D936N</title>
	<circle cx="1241.9" cy="400.9" r="3.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-03  G24620T  Europe=2 [2.2%]  surface glycoprotein, A1020S</title>
	<circle cx="1244.8" cy="344.8" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04 Europe: 2280 samples</title>
	<line x1="1201.4" y1="1180.0" x2="1202.4" y2="1165.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-04 North America: 251 samples</title>
	<line x1="1202.4" y1="1165.0" x2="1203.2" y2="1154.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-04 Oceania: 3 samples</title>
	<line x1="1203.2" y1="1154.2" x2="1203.4" y2="1151.5" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-04 Asia: 11 samples</title>
	<line x1="1203.4" y1="1151.5" x2="1203.7" y2="1146.6" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-04  C21575T  North America=8 [3.2%]  surface glycoprotein, L5F</title>
	<circle cx="1212.4" cy="1022.3" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C21575T  North America=8 [3.2%] Europe=44 [1.9%]  surface glycoprotein, L5F</title>
	<circle cx="1212.4" cy="1022.3" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  TT21576T  Europe=6 [0.3%]  surface glycoprotein, V6F</title>
	<circle cx="1212.4" cy="1022.0" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C21597T  Europe=16 [0.7%]  surface glycoprotein, S12F</title>
	<circle cx="1212.8" cy="1017.4" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G21600T  North America=8 [3.2%]  surface glycoprotein, S13I</title>
	<circle cx="1212.8" cy="1016.7" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G21600T  North America=8 [3.2%] Europe=4 [0.2%]  surface glycoprotein, S13I</title>
	<circle cx="1212.8" cy="1016.7" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C21614T  Europe=139 [6.1%]  surface glycoprotein, L18F</title>
	<circle cx="1213.0" cy="1013.6" r="3.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C21618T  Europe=7 [0.3%]  surface glycoprotein, T19I</title>
	<circle cx="1213.1" cy="1012.7" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C21621T  Europe=5 [0.2%]  surface glycoprotein, T20I</title>
	<circle cx="1213.1" cy="1012.0" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C21636T  Europe=2 [0.1%]  surface glycoprotein, P25L</title>
	<circle cx="1213.4" cy="1008.7" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C21638T  North America=3 [1.2%]  surface glycoprotein, P26S</title>
	<circle cx="1213.4" cy="1008.3" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C21639A  Europe=15 [0.7%]  surface glycoprotein, P26H</title>
	<circle cx="1213.4" cy="1008.0" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G21701A  Europe=3 [0.1%]  surface glycoprotein, V47I</title>
	<circle cx="1214.4" cy="994.3" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C21707T  Europe=10 [0.4%]  surface glycoprotein, H49Y</title>
	<circle cx="1214.5" cy="992.9" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G21724T  Europe=2 [0.1%]  surface glycoprotein, L54F</title>
	<circle cx="1214.7" cy="989.2" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  T21738C  Europe=7 [0.3%]  surface glycoprotein, F59S</title>
	<circle cx="1215.0" cy="986.0" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G21754T  Europe=3 [0.1%]  surface glycoprotein, W64C</title>
	<circle cx="1215.2" cy="982.5" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C21762T  North America=2 [0.8%]  surface glycoprotein, A67V</title>
	<circle cx="1215.3" cy="980.7" r="1.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C21762T  North America=2 [0.8%] Europe=3 [0.1%]  surface glycoprotein, A67V</title>
	<circle cx="1215.3" cy="980.7" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C21846A  North America=2 [0.8%]  surface glycoprotein, T95N</title>
	<circle cx="1216.6" cy="962.1" r="1.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C21846T  Europe=7 [0.3%]  surface glycoprotein, T95I</title>
	<circle cx="1216.6" cy="962.1" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C21855T  Europe=170 [7.5%]  surface glycoprotein, S98F</title>
	<circle cx="1216.8" cy="960.1" r="3.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G21974T  Europe=3 [0.1%]  surface glycoprotein, D138Y</title>
	<circle cx="1218.6" cy="933.6" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G21986A  North America=3 [1.2%]  surface glycoprotein, G142S</title>
	<circle cx="1218.8" cy="930.9" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G21989T  Europe=57 [2.5%]  surface glycoprotein, V143F</title>
	<circle cx="1218.9" cy="930.3" r="2.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  ATTA21993A  Europe=25 [1.1%]  surface glycoprotein, Y145H</title>
	<circle cx="1218.9" cy="929.4" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  ATTA21993A  Europe=25 [1.1%] North America=2 [0.8%]  surface glycoprotein, Y145H</title>
	<circle cx="1218.9" cy="929.4" r="1.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G22018T  North America=8 [3.2%]  surface glycoprotein, W152C</title>
	<circle cx="1219.3" cy="923.8" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G22018T  North America=8 [3.2%] Europe=3 [0.1%]  surface glycoprotein, W152C</title>
	<circle cx="1219.3" cy="923.8" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  T22020C  Europe=3 [0.1%]  surface glycoprotein, M153T</title>
	<circle cx="1219.3" cy="923.4" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C22079A  North America=3 [1.2%]  surface glycoprotein, Q173K</title>
	<circle cx="1220.3" cy="910.3" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C22088T  Europe=7 [0.3%]  surface glycoprotein, L176F</title>
	<circle cx="1220.4" cy="908.3" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G22094A  North America=2 [0.8%]  surface glycoprotein, D178N</title>
	<circle cx="1220.5" cy="907.0" r="1.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  A22101T  North America=3 [1.2%]  surface glycoprotein, E180V</title>
	<circle cx="1220.6" cy="905.4" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G22103C  Europe=3 [0.1%]  surface glycoprotein, G181R</title>
	<circle cx="1220.6" cy="905.0" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G22104T  Europe=2 [0.1%]  surface glycoprotein, G181V</title>
	<circle cx="1220.6" cy="904.7" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C22127T  Europe=3 [0.1%]  surface glycoprotein, L189F</title>
	<circle cx="1221.0" cy="899.6" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  ATTA22190A  Europe=10 [0.4%]  surface glycoprotein, I210N</title>
	<circle cx="1222.0" cy="885.6" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G22203T  Europe=4 [0.2%]  surface glycoprotein, R214L</title>
	<circle cx="1222.2" cy="882.7" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G22205C  Europe=4 [0.2%]  surface glycoprotein, D215H</title>
	<circle cx="1222.2" cy="882.3" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G22205T  North America=2 [0.8%]  surface glycoprotein, D215Y</title>
	<circle cx="1222.2" cy="882.3" r="1.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C22227T  Europe=1343 [58.9%]  surface glycoprotein, A222V</title>
	<circle cx="1222.6" cy="877.4" r="7.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C22227T  North America=2 [0.8%]  surface glycoprotein, A222V</title>
	<circle cx="1222.6" cy="877.4" r="1.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  A22259G  Europe=38 [1.7%]  surface glycoprotein, I233V</title>
	<circle cx="1223.1" cy="870.3" r="1.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G22289T  Europe=2 [0.1%]  surface glycoprotein, A243S</title>
	<circle cx="1223.5" cy="863.6" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C22314T  Europe=2 [0.1%]  surface glycoprotein, P251L</title>
	<circle cx="1223.9" cy="858.1" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  A22320G  Europe=3 [0.1%]  surface glycoprotein, D253G</title>
	<circle cx="1224.0" cy="856.7" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C22329T  Europe=2 [0.1%]  surface glycoprotein, S256L</title>
	<circle cx="1224.1" cy="854.7" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G22335T  Europe=2 [0.1%]  surface glycoprotein, W258L</title>
	<circle cx="1224.2" cy="853.4" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C22338T  Europe=2 [0.1%]  surface glycoprotein, T259I</title>
	<circle cx="1224.3" cy="852.7" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G22343C  Europe=9 [0.4%]  surface glycoprotein, G261R</title>
	<circle cx="1224.4" cy="851.6" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G22346T  Europe=19 [0.8%]  surface glycoprotein, A262S</title>
	<circle cx="1224.4" cy="851.0" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C22350T  Europe=4 [0.2%]  surface glycoprotein, A263V</title>
	<circle cx="1224.5" cy="850.1" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C22377T  Europe=15 [0.7%]  surface glycoprotein, P272L</title>
	<circle cx="1224.9" cy="844.1" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C22482T  Europe=2 [0.1%]  surface glycoprotein, T307I</title>
	<circle cx="1226.5" cy="820.7" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G22661C  North America=2 [0.8%]  surface glycoprotein, V367L</title>
	<circle cx="1229.3" cy="781.0" r="1.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C22716T  Europe=3 [0.1%]  surface glycoprotein, T385I</title>
	<circle cx="1230.2" cy="768.8" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G22817T  North America=2 [0.8%]  surface glycoprotein, A419S</title>
	<circle cx="1231.7" cy="746.3" r="1.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C22879A  Asia=6 [54.5%]  surface glycoprotein, N439K</title>
	<circle cx="1232.7" cy="732.5" r="7.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C22879A  Europe=257 [11.3%]  surface glycoprotein, N439K</title>
	<circle cx="1232.7" cy="732.5" r="4.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  T22882G  Europe=5 [0.2%]  surface glycoprotein, N440K</title>
	<circle cx="1232.7" cy="731.9" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  T22917G  North America=8 [3.2%]  surface glycoprotein, L452R</title>
	<circle cx="1233.3" cy="724.1" r="2.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  T22917G  North America=8 [3.2%] Europe=6 [0.3%]  surface glycoprotein, L452R</title>
	<circle cx="1233.3" cy="724.1" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C22986T  Europe=4 [0.2%]  surface glycoprotein, A475V</title>
	<circle cx="1234.4" cy="708.8" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G22992A  Europe=277 [12.1%]  surface glycoprotein, S477N</title>
	<circle cx="1234.4" cy="707.4" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C22993G  Europe=19 [0.8%]  surface glycoprotein, S477R</title>
	<circle cx="1234.5" cy="707.2" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G23009T  Europe=2 [0.1%]  surface glycoprotein, V483F</title>
	<circle cx="1234.7" cy="703.7" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G23012A  Europe=2 [0.1%]  surface glycoprotein, E484K</title>
	<circle cx="1234.8" cy="703.0" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  T23042C  North America=3 [1.2%]  surface glycoprotein, S494P</title>
	<circle cx="1235.2" cy="696.3" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  T23042C  North America=3 [1.2%] Europe=2 [0.1%]  surface glycoprotein, S494P</title>
	<circle cx="1235.2" cy="696.3" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  A23063T  North America=2 [0.8%]  surface glycoprotein, N501Y</title>
	<circle cx="1235.5" cy="691.7" r="1.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  A23063T  North America=2 [0.8%] Europe=16 [0.7%]  surface glycoprotein, N501Y</title>
	<circle cx="1235.5" cy="691.7" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  A23064C  North America=4 [1.6%]  surface glycoprotein, N501T</title>
	<circle cx="1235.6" cy="691.4" r="1.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C23111T  Europe=2 [0.1%]  surface glycoprotein, L517F</title>
	<circle cx="1236.3" cy="681.0" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G23120T  Europe=2 [0.1%]  surface glycoprotein, A520S</title>
	<circle cx="1236.4" cy="679.0" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  A23180C  Europe=6 [0.3%]  surface glycoprotein, N540H</title>
	<circle cx="1237.4" cy="665.7" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C23202T  Europe=8 [0.4%]  surface glycoprotein, T547I</title>
	<circle cx="1237.7" cy="660.8" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C23271A  North America=2 [0.8%]  surface glycoprotein, A570D</title>
	<circle cx="1238.8" cy="645.5" r="1.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C23271A  North America=2 [0.8%] Europe=15 [0.7%]  surface glycoprotein, A570D</title>
	<circle cx="1238.8" cy="645.5" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  A23403G  North America=251 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1240.8" cy="616.1" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  A23403G  North America=251 [100.0%] Asia=11 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1240.8" cy="616.1" r="8.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  A23403G  North America=251 [100.0%] Asia=11 [100.0%] Oceania=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1240.8" cy="616.1" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  A23403G  North America=251 [100.0%] Asia=11 [100.0%] Oceania=3 [100.0%] Europe=2276 [99.8%]  surface glycoprotein, D614G</title>
	<circle cx="1240.8" cy="616.1" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C23423T  Europe=2 [0.1%]  surface glycoprotein, P621S</title>
	<circle cx="1241.1" cy="611.7" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G23426A  Europe=4 [0.2%]  surface glycoprotein, V622I</title>
	<circle cx="1241.2" cy="611.0" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G23438T  Europe=5 [0.2%]  surface glycoprotein, A626S</title>
	<circle cx="1241.4" cy="608.3" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C23453T  North America=2 [0.8%]  surface glycoprotein, P631S</title>
	<circle cx="1241.6" cy="605.0" r="1.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C23481T  Europe=3 [0.1%]  surface glycoprotein, S640F</title>
	<circle cx="1242.0" cy="598.8" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G23522C  Europe=5 [0.2%]  surface glycoprotein, E654Q</title>
	<circle cx="1242.7" cy="589.7" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C23525T  Europe=2 [0.1%]  surface glycoprotein, H655Y</title>
	<circle cx="1242.7" cy="589.0" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  A23579G  Europe=13 [0.6%]  surface glycoprotein, S673G</title>
	<circle cx="1243.6" cy="577.0" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G23580C  Europe=20 [0.9%]  surface glycoprotein, S673T</title>
	<circle cx="1243.6" cy="576.8" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G23587T  Europe=3 [0.1%]  surface glycoprotein, Q675H</title>
	<circle cx="1243.7" cy="575.2" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G23587C  North America=3 [1.2%]  surface glycoprotein, Q675H</title>
	<circle cx="1243.7" cy="575.2" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G23593T  North America=10 [4.0%]  surface glycoprotein, Q677H</title>
	<circle cx="1243.8" cy="573.9" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G23593T  North America=10 [4.0%] Europe=27 [1.2%]  surface glycoprotein, Q677H</title>
	<circle cx="1243.8" cy="573.9" r="1.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G23593C  North America=5 [2.0%]  surface glycoprotein, Q677H</title>
	<circle cx="1243.8" cy="573.9" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  T23599A  Europe=21 [0.9%]  surface glycoprotein, N679K</title>
	<circle cx="1243.9" cy="572.6" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C23604A  North America=12 [4.8%]  surface glycoprotein, P681H</title>
	<circle cx="1244.0" cy="571.5" r="3.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C23604A  North America=12 [4.8%] Europe=27 [1.2%]  surface glycoprotein, P681H</title>
	<circle cx="1244.0" cy="571.5" r="1.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C23604G  Asia=7 [63.6%]  surface glycoprotein, P681R</title>
	<circle cx="1244.0" cy="571.5" r="7.2" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C23604G  Europe=3 [0.1%]  surface glycoprotein, P681R</title>
	<circle cx="1244.0" cy="571.5" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C23625T  Europe=12 [0.5%]  surface glycoprotein, A688V</title>
	<circle cx="1244.3" cy="566.8" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C23673T  Europe=2 [0.1%]  surface glycoprotein, S704L</title>
	<circle cx="1245.0" cy="556.1" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C23709T  Europe=19 [0.8%]  surface glycoprotein, T716I</title>
	<circle cx="1245.6" cy="548.1" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C23709T  Europe=19 [0.8%] North America=2 [0.8%]  surface glycoprotein, T716I</title>
	<circle cx="1245.6" cy="548.1" r="1.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  A23756G  North America=4 [1.6%]  surface glycoprotein, T732A</title>
	<circle cx="1246.3" cy="537.7" r="1.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  A23780C  Europe=9 [0.4%]  surface glycoprotein, M740L</title>
	<circle cx="1246.7" cy="532.4" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C23802T  North America=2 [0.8%]  surface glycoprotein, T747I</title>
	<circle cx="1247.0" cy="527.5" r="1.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G23868T  North America=3 [1.2%]  surface glycoprotein, G769V</title>
	<circle cx="1248.1" cy="512.8" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G23876A  Europe=3 [0.1%]  surface glycoprotein, V772I</title>
	<circle cx="1248.2" cy="511.0" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G24000T  Europe=26 [1.1%]  surface glycoprotein, S813I</title>
	<circle cx="1250.1" cy="483.5" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G24087A  North America=2 [0.8%]  surface glycoprotein, G842D</title>
	<circle cx="1251.5" cy="464.2" r="1.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G24095T  North America=2 [0.8%]  surface glycoprotein, A845S</title>
	<circle cx="1251.6" cy="462.4" r="1.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C24099T  Europe=2 [0.1%]  surface glycoprotein, A846V</title>
	<circle cx="1251.6" cy="461.5" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C24138T  North America=3 [1.2%]  surface glycoprotein, T859I</title>
	<circle cx="1252.2" cy="452.8" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C24138T  North America=3 [1.2%] Europe=7 [0.3%]  surface glycoprotein, T859I</title>
	<circle cx="1252.2" cy="452.8" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C24213T  Europe=3 [0.1%]  surface glycoprotein, S884F</title>
	<circle cx="1253.4" cy="436.2" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G24257T  Europe=9 [0.4%]  surface glycoprotein, A899S</title>
	<circle cx="1254.1" cy="426.4" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C24374T  Europe=3 [0.1%]  surface glycoprotein, L938F</title>
	<circle cx="1255.9" cy="400.4" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C24378T  Europe=14 [0.6%]  surface glycoprotein, S939F</title>
	<circle cx="1256.0" cy="399.5" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  A24402G  Europe=4 [0.2%]  surface glycoprotein, K947R</title>
	<circle cx="1256.3" cy="394.2" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  T24506G  North America=2 [0.8%]  surface glycoprotein, S982A</title>
	<circle cx="1258.0" cy="371.1" r="1.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  T24506G  North America=2 [0.8%] Europe=15 [0.7%]  surface glycoprotein, S982A</title>
	<circle cx="1258.0" cy="371.1" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G24620T  Europe=31 [1.4%]  surface glycoprotein, A1020S</title>
	<circle cx="1259.7" cy="345.7" r="1.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G24712T  Europe=2 [0.1%]  surface glycoprotein, M1050I</title>
	<circle cx="1261.2" cy="325.3" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G24712C  Europe=5 [0.2%]  surface glycoprotein, M1050I</title>
	<circle cx="1261.2" cy="325.3" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C24767T  Europe=3 [0.1%]  surface glycoprotein, P1069S</title>
	<circle cx="1262.0" cy="313.1" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  A24774T  Europe=5 [0.2%]  surface glycoprotein, Q1071L</title>
	<circle cx="1262.1" cy="311.5" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  A24780C  Europe=47 [2.1%]  surface glycoprotein, K1073T</title>
	<circle cx="1262.2" cy="310.2" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G24794T  Europe=47 [2.1%]  surface glycoprotein, A1078S</title>
	<circle cx="1262.4" cy="307.1" r="1.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  A24813G  Europe=2 [0.1%]  surface glycoprotein, D1084G</title>
	<circle cx="1262.7" cy="302.9" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  T24814A  Europe=10 [0.4%]  surface glycoprotein, D1084E</title>
	<circle cx="1262.7" cy="302.6" r="0.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G24816C  Europe=7 [0.3%]  surface glycoprotein, G1085A</title>
	<circle cx="1262.8" cy="302.2" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G24821T  Europe=3 [0.1%]  surface glycoprotein, A1087S</title>
	<circle cx="1262.9" cy="301.1" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G24914C  North America=2 [0.8%]  surface glycoprotein, D1118H</title>
	<circle cx="1264.3" cy="280.4" r="1.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G24914C  North America=2 [0.8%] Europe=15 [0.7%]  surface glycoprotein, D1118H</title>
	<circle cx="1264.3" cy="280.4" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G24926T  Europe=4 [0.2%]  surface glycoprotein, V1122L</title>
	<circle cx="1264.5" cy="277.8" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  T24960C  North America=2 [0.8%]  surface glycoprotein, V1133A</title>
	<circle cx="1265.0" cy="270.2" r="1.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G24977C  Europe=2 [0.1%]  surface glycoprotein, D1139H</title>
	<circle cx="1265.3" cy="266.4" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G24998C  Europe=2 [0.1%]  surface glycoprotein, D1146H</title>
	<circle cx="1265.6" cy="261.8" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G25019T  North America=3 [1.2%]  surface glycoprotein, D1153Y</title>
	<circle cx="1265.9" cy="257.1" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  T25028C  Europe=5 [0.2%]  surface glycoprotein, F1156L</title>
	<circle cx="1266.1" cy="255.1" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C25046T  Europe=18 [0.8%]  surface glycoprotein, P1162S</title>
	<circle cx="1266.4" cy="251.1" r="1.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C25047G  Europe=3 [0.1%]  surface glycoprotein, P1162R</title>
	<circle cx="1266.4" cy="250.9" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G25049T  North America=2 [0.8%]  surface glycoprotein, D1163Y</title>
	<circle cx="1266.4" cy="250.4" r="1.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G25049T  North America=2 [0.8%] Europe=17 [0.7%]  surface glycoprotein, D1163Y</title>
	<circle cx="1266.4" cy="250.4" r="1.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G25135T  Europe=2 [0.1%]  surface glycoprotein, K1191N</title>
	<circle cx="1267.7" cy="231.3" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G25157T  Europe=4 [0.2%]  surface glycoprotein, D1199Y</title>
	<circle cx="1268.1" cy="226.4" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G25166C  Europe=8 [0.4%]  surface glycoprotein, E1202Q</title>
	<circle cx="1268.2" cy="224.4" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G25217T  Europe=36 [1.6%]  surface glycoprotein, G1219C</title>
	<circle cx="1269.0" cy="213.1" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G25218T  Europe=5 [0.2%]  surface glycoprotein, G1219V</title>
	<circle cx="1269.0" cy="212.9" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G25229A  Europe=4 [0.2%]  surface glycoprotein, G1223S</title>
	<circle cx="1269.2" cy="210.4" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G25244T  North America=6 [2.4%]  surface glycoprotein, V1228L</title>
	<circle cx="1269.4" cy="207.1" r="2.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G25244T  North America=6 [2.4%] Europe=3 [0.1%]  surface glycoprotein, V1228L</title>
	<circle cx="1269.4" cy="207.1" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C25317T  Europe=4 [0.2%]  surface glycoprotein, S1252F</title>
	<circle cx="1270.6" cy="190.9" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G25352T  Europe=7 [0.3%]  surface glycoprotein, V1264L</title>
	<circle cx="1271.1" cy="183.1" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  A25420C  North America=2 [0.8%]  ORF3a protein, I10L</title>
	<circle cx="1272.2" cy="168.0" r="1.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C25427T  Europe=2 [0.1%]  ORF3a protein, T12I</title>
	<circle cx="1272.3" cy="166.4" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G25429T  Europe=2 [0.1%]  ORF3a protein, V13L</title>
	<circle cx="1272.3" cy="166.0" r="0.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C25433T  Europe=3 [0.1%]  ORF3a protein, T14I</title>
	<circle cx="1272.4" cy="165.1" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G25437T  Europe=5 [0.2%]  ORF3a protein, L15F</title>
	<circle cx="1272.4" cy="164.2" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G25440T  North America=2 [0.8%]  ORF3a protein, K16N</title>
	<circle cx="1272.5" cy="163.6" r="1.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  A25450G  Europe=71 [3.1%]  ORF3a protein, I20V</title>
	<circle cx="1272.6" cy="161.3" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G25459T  Europe=5 [0.2%]  ORF3a protein, A23S</title>
	<circle cx="1272.8" cy="159.3" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C25460T  Europe=4 [0.2%]  ORF3a protein, A23V</title>
	<circle cx="1272.8" cy="159.1" r="0.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G25471T  Europe=33 [1.4%]  ORF3a protein, D27Y</title>
	<circle cx="1273.0" cy="156.7" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G25481T  Europe=12 [0.5%]  ORF3a protein, R30L</title>
	<circle cx="1273.1" cy="154.4" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  C25487T  Europe=3 [0.1%]  ORF3a protein, T32I</title>
	<circle cx="1273.2" cy="153.1" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-04  G25489T  Europe=3 [0.1%]  ORF3a protein, A33S</title>
	<circle cx="1273.2" cy="152.7" r="0.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05 Europe: 59 samples</title>
	<line x1="1201.7" y1="1180.1" x2="1202.4" y2="1172.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-05 North America: 121 samples</title>
	<line x1="1202.4" y1="1172.1" x2="1203.3" y2="1162.8" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-05 Asia: 3 samples</title>
	<line x1="1203.3" y1="1162.8" x2="1203.5" y2="1160.1" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-05  C21575T  North America=3 [2.5%]  surface glycoprotein, L5F</title>
	<circle cx="1215.5" cy="1022.5" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  G21578T  Europe=2 [3.4%]  surface glycoprotein, V6F</title>
	<circle cx="1215.6" cy="1021.8" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  G21586T  North America=2 [1.7%]  surface glycoprotein, L8F</title>
	<circle cx="1215.7" cy="1020.1" r="1.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  C21597T  Europe=3 [5.1%]  surface glycoprotein, S12F</title>
	<circle cx="1216.0" cy="1017.6" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  G21600T  North America=6 [5.0%]  surface glycoprotein, S13I</title>
	<circle cx="1216.0" cy="1017.0" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  C21614T  Europe=14 [23.7%]  surface glycoprotein, L18F</title>
	<circle cx="1216.3" cy="1013.9" r="5.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  G21776A  North America=2 [1.7%]  surface glycoprotein, G72R</title>
	<circle cx="1219.4" cy="977.9" r="1.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  C21855T  Europe=11 [18.6%]  surface glycoprotein, S98F</title>
	<circle cx="1221.0" cy="960.4" r="5.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  G21986A  North America=3 [2.5%]  surface glycoprotein, G142S</title>
	<circle cx="1223.5" cy="931.3" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  ATTA21993A  Europe=4 [6.8%]  surface glycoprotein, Y145H</title>
	<circle cx="1223.6" cy="929.8" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  G22018T  North America=6 [5.0%]  surface glycoprotein, W152C</title>
	<circle cx="1224.1" cy="924.2" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  A22029C  Europe=2 [3.4%]  surface glycoprotein, E156A</title>
	<circle cx="1224.3" cy="921.8" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  C22079A  North America=2 [1.7%]  surface glycoprotein, Q173K</title>
	<circle cx="1225.3" cy="910.7" r="1.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  C22082T  Europe=2 [3.4%]  surface glycoprotein, P174S</title>
	<circle cx="1225.4" cy="910.0" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  A22101T  North America=3 [2.5%]  surface glycoprotein, E180V</title>
	<circle cx="1225.7" cy="905.8" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  C22227T  Europe=22 [37.3%]  surface glycoprotein, A222V</title>
	<circle cx="1228.2" cy="877.8" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  C22323T  North America=2 [1.7%]  surface glycoprotein, S254F</title>
	<circle cx="1230.0" cy="856.5" r="1.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  C22879A  Europe=4 [6.8%]  surface glycoprotein, N439K</title>
	<circle cx="1240.8" cy="733.2" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  T22917G  North America=6 [5.0%]  surface glycoprotein, L452R</title>
	<circle cx="1241.6" cy="724.8" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  G22992A  Europe=4 [6.8%]  surface glycoprotein, S477N</title>
	<circle cx="1243.0" cy="708.1" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  G23012A  North America=3 [2.5%]  surface glycoprotein, E484K</title>
	<circle cx="1243.4" cy="703.7" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  A23063T  Europe=4 [6.8%]  surface glycoprotein, N501Y</title>
	<circle cx="1244.4" cy="692.4" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  A23064C  North America=2 [1.7%]  surface glycoprotein, N501T</title>
	<circle cx="1244.4" cy="692.1" r="1.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  C23271A  Europe=4 [6.8%]  surface glycoprotein, A570D</title>
	<circle cx="1248.5" cy="646.2" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  A23403G  North America=121 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1251.0" cy="616.9" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  A23403G  North America=121 [100.0%] Europe=59 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1251.0" cy="616.9" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  A23403G  North America=121 [100.0%] Europe=59 [100.0%] Asia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1251.0" cy="616.9" r="8.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  C23481T  North America=2 [1.7%]  surface glycoprotein, S640F</title>
	<circle cx="1252.5" cy="599.6" r="1.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  G23593T  North America=12 [9.9%]  surface glycoprotein, Q677H</title>
	<circle cx="1254.7" cy="574.8" r="4.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  C23604A  Europe=7 [11.9%]  surface glycoprotein, P681H</title>
	<circle cx="1254.9" cy="572.3" r="4.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  C23604A  North America=7 [5.8%]  surface glycoprotein, P681H</title>
	<circle cx="1254.9" cy="572.3" r="3.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  C23604G  North America=3 [2.5%]  surface glycoprotein, P681R</title>
	<circle cx="1254.9" cy="572.3" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  C23709T  Europe=4 [6.8%]  surface glycoprotein, T716I</title>
	<circle cx="1257.0" cy="549.0" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  G23868T  North America=3 [2.5%]  surface glycoprotein, G769V</title>
	<circle cx="1260.0" cy="513.8" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  G23873T  Europe=2 [3.4%]  surface glycoprotein, A771S</title>
	<circle cx="1260.1" cy="512.6" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  G24095T  North America=2 [1.7%]  surface glycoprotein, A845S</title>
	<circle cx="1264.4" cy="463.4" r="1.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  C24099T  Europe=2 [3.4%]  surface glycoprotein, A846V</title>
	<circle cx="1264.5" cy="462.5" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  T24506G  Europe=4 [6.8%]  surface glycoprotein, S982A</title>
	<circle cx="1272.4" cy="372.2" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  C24809T  North America=2 [1.7%]  surface glycoprotein, H1083Y</title>
	<circle cx="1278.3" cy="305.0" r="1.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  T24903C  North America=3 [2.5%]  surface glycoprotein, I1114T</title>
	<circle cx="1280.1" cy="284.1" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  G24914C  Europe=4 [6.8%]  surface glycoprotein, D1118H</title>
	<circle cx="1280.3" cy="281.7" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  G25049T  North America=2 [1.7%]  surface glycoprotein, D1163Y</title>
	<circle cx="1283.0" cy="251.7" r="1.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  G25244T  North America=2 [1.7%]  surface glycoprotein, V1228L</title>
	<circle cx="1286.7" cy="208.5" r="1.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  G25429T  Europe=2 [3.4%]  ORF3a protein, V13L</title>
	<circle cx="1290.3" cy="167.4" r="2.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-05  A25448G  North America=2 [1.7%]  ORF3a protein, E19G</title>
	<circle cx="1290.7" cy="163.2" r="1.7" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06 Europe: 36 samples</title>
	<line x1="1202.1" y1="1180.1" x2="1202.8" y2="1173.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-06 North America: 163 samples</title>
	<line x1="1202.8" y1="1173.1" x2="1203.9" y2="1163.2" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-06 Oceania: 2 samples</title>
	<line x1="1203.9" y1="1163.2" x2="1204.1" y2="1161.0" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-06 Africa: 4 samples</title>
	<line x1="1204.1" y1="1161.0" x2="1204.4" y2="1157.9" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-06  C21575T  North America=8 [4.9%]  surface glycoprotein, L5F</title>
	<circle cx="1218.6" cy="1022.8" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  G21600T  North America=8 [4.9%]  surface glycoprotein, S13I</title>
	<circle cx="1219.2" cy="1017.3" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  C21621T  North America=3 [1.8%]  surface glycoprotein, T20I</title>
	<circle cx="1219.7" cy="1012.6" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  C21648T  North America=3 [1.8%]  surface glycoprotein, T29I</title>
	<circle cx="1220.3" cy="1006.6" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  A21849G  Europe=3 [8.3%]  surface glycoprotein, E96G</title>
	<circle cx="1225.0" cy="962.1" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  C21855T  Europe=4 [11.1%]  surface glycoprotein, S98F</title>
	<circle cx="1225.1" cy="960.8" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  G21974T  North America=2 [1.2%]  surface glycoprotein, D138Y</title>
	<circle cx="1227.9" cy="934.4" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  ATTA21993A  Europe=12 [33.3%]  surface glycoprotein, Y145H</title>
	<circle cx="1228.4" cy="930.2" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  ATTA21993A  North America=2 [1.2%]  surface glycoprotein, Y145H</title>
	<circle cx="1228.4" cy="930.2" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  G22018T  North America=8 [4.9%]  surface glycoprotein, W152C</title>
	<circle cx="1228.9" cy="924.7" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  C22088T  North America=2 [1.2%]  surface glycoprotein, L176F</title>
	<circle cx="1230.6" cy="909.2" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  G22205C  North America=2 [1.2%]  surface glycoprotein, D215H</title>
	<circle cx="1233.3" cy="883.3" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  C22227T  Africa=2 [50.0%]  surface glycoprotein, A222V</title>
	<circle cx="1233.8" cy="878.4" r="6.8" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  C22227T  Europe=6 [16.7%]  surface glycoprotein, A222V</title>
	<circle cx="1233.8" cy="878.4" r="5.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  T22917G  North America=8 [4.9%]  surface glycoprotein, L452R</title>
	<circle cx="1249.9" cy="725.6" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  G22992A  Europe=9 [25.0%]  surface glycoprotein, S477N</title>
	<circle cx="1251.6" cy="708.9" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  A23063T  Europe=12 [33.3%]  surface glycoprotein, N501Y</title>
	<circle cx="1253.3" cy="693.2" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  A23063T  North America=4 [2.5%]  surface glycoprotein, N501Y</title>
	<circle cx="1253.3" cy="693.2" r="2.2" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  A23064C  North America=5 [3.1%]  surface glycoprotein, N501T</title>
	<circle cx="1253.3" cy="693.0" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  C23271A  Europe=12 [33.3%]  surface glycoprotein, A570D</title>
	<circle cx="1258.1" cy="647.1" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  C23271A  North America=2 [1.2%]  surface glycoprotein, A570D</title>
	<circle cx="1258.1" cy="647.1" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  C23277T  North America=3 [1.8%]  surface glycoprotein, T572I</title>
	<circle cx="1258.2" cy="645.8" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  A23403G  Europe=36 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1261.2" cy="617.9" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  A23403G  Europe=36 [100.0%] Africa=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1261.2" cy="617.9" r="8.0" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  A23403G  Europe=36 [100.0%] Africa=4 [100.0%] Oceania=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1261.2" cy="617.9" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  A23403G  Europe=36 [100.0%] Africa=4 [100.0%] Oceania=2 [100.0%] North America=162 [99.4%]  surface glycoprotein, D614G</title>
	<circle cx="1261.2" cy="617.9" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  G23587C  North America=2 [1.2%]  surface glycoprotein, Q675H</title>
	<circle cx="1265.5" cy="577.2" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  G23593T  North America=8 [4.9%]  surface glycoprotein, Q677H</title>
	<circle cx="1265.6" cy="575.8" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  G23593C  North America=3 [1.8%]  surface glycoprotein, Q677H</title>
	<circle cx="1265.6" cy="575.8" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  C23604A  Europe=12 [33.3%]  surface glycoprotein, P681H</title>
	<circle cx="1265.9" cy="573.4" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  C23604A  North America=33 [20.2%]  surface glycoprotein, P681H</title>
	<circle cx="1265.9" cy="573.4" r="5.3" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  C23709T  Europe=12 [33.3%]  surface glycoprotein, T716I</title>
	<circle cx="1268.3" cy="550.1" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  C23709T  North America=2 [1.2%]  surface glycoprotein, T716I</title>
	<circle cx="1268.3" cy="550.1" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  C24099T  Europe=3 [8.3%]  surface glycoprotein, A846V</title>
	<circle cx="1277.4" cy="463.7" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  C24138T  North America=24 [14.7%]  surface glycoprotein, T859I</title>
	<circle cx="1278.3" cy="455.1" r="4.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  G24368A  North America=3 [1.8%]  surface glycoprotein, D936N</title>
	<circle cx="1283.6" cy="404.2" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  T24506G  Europe=12 [33.3%]  surface glycoprotein, S982A</title>
	<circle cx="1286.9" cy="373.6" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  T24506G  North America=2 [1.2%]  surface glycoprotein, S982A</title>
	<circle cx="1286.9" cy="373.6" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  G24680T  North America=3 [1.8%]  surface glycoprotein, V1040F</title>
	<circle cx="1290.9" cy="335.1" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  A24774T  North America=3 [1.8%]  surface glycoprotein, Q1071L</title>
	<circle cx="1293.1" cy="314.2" r="1.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  G24914C  Europe=12 [33.3%]  surface glycoprotein, D1118H</title>
	<circle cx="1296.4" cy="283.2" r="6.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  G24914C  North America=2 [1.2%]  surface glycoprotein, D1118H</title>
	<circle cx="1296.4" cy="283.2" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  A24956G  North America=24 [14.7%]  surface glycoprotein, I1132V</title>
	<circle cx="1297.3" cy="273.9" r="4.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  G25088T  North America=2 [1.2%]  surface glycoprotein, V1176F</title>
	<circle cx="1300.4" cy="244.7" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  T25268A  North America=2 [1.2%]  surface glycoprotein, C1236S</title>
	<circle cx="1304.6" cy="204.8" r="1.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-06  G25273T  Europe=2 [5.6%]  surface glycoprotein, M1237I</title>
	<circle cx="1304.7" cy="203.7" r="3.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07 Europe: 23 samples</title>
	<line x1="1202.4" y1="1180.1" x2="1203.2" y2="1174.0" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-07 North America: 103 samples</title>
	<line x1="1203.2" y1="1174.0" x2="1204.3" y2="1165.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-07 Asia: 3 samples</title>
	<line x1="1204.3" y1="1165.0" x2="1204.6" y2="1162.3" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-07  C21575T  North America=3 [2.9%]  surface glycoprotein, L5F</title>
	<circle cx="1221.7" cy="1023.2" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  G21600T  North America=10 [9.7%]  surface glycoprotein, S13I</title>
	<circle cx="1222.4" cy="1017.6" r="4.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  C21614T  Europe=2 [8.7%]  surface glycoprotein, L18F</title>
	<circle cx="1222.8" cy="1014.5" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  C21621T  North America=3 [2.9%]  surface glycoprotein, T20I</title>
	<circle cx="1223.0" cy="1013.0" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  G21800T  North America=2 [1.9%]  surface glycoprotein, D80Y</title>
	<circle cx="1227.8" cy="973.4" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  C21846T  North America=2 [1.9%]  surface glycoprotein, T95I</title>
	<circle cx="1229.1" cy="963.2" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  C21855T  Europe=7 [30.4%]  surface glycoprotein, S98F</title>
	<circle cx="1229.3" cy="961.3" r="6.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  ATTA21993A  Europe=3 [13.0%]  surface glycoprotein, Y145H</title>
	<circle cx="1233.1" cy="930.8" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  ATTA21993A  North America=2 [1.9%]  surface glycoprotein, Y145H</title>
	<circle cx="1233.1" cy="930.8" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  G22018T  North America=10 [9.7%]  surface glycoprotein, W152C</title>
	<circle cx="1233.7" cy="925.2" r="4.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  C22227T  Europe=7 [30.4%]  surface glycoprotein, A222V</title>
	<circle cx="1239.4" cy="879.0" r="6.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  C22227T  North America=2 [1.9%]  surface glycoprotein, A222V</title>
	<circle cx="1239.4" cy="879.0" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  T22917G  North America=10 [9.7%]  surface glycoprotein, L452R</title>
	<circle cx="1258.1" cy="726.5" r="4.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  G22992A  Europe=5 [21.7%]  surface glycoprotein, S477N</title>
	<circle cx="1260.2" cy="709.9" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  A23063T  Europe=4 [17.4%]  surface glycoprotein, N501Y</title>
	<circle cx="1262.1" cy="694.2" r="5.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  A23064C  North America=4 [3.9%]  surface glycoprotein, N501T</title>
	<circle cx="1262.1" cy="694.0" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  G23120T  North America=2 [1.9%]  surface glycoprotein, A520S</title>
	<circle cx="1263.6" cy="681.6" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  C23271A  Europe=3 [13.0%]  surface glycoprotein, A570D</title>
	<circle cx="1267.7" cy="648.2" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  C23277T  North America=2 [1.9%]  surface glycoprotein, T572I</title>
	<circle cx="1267.9" cy="646.9" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  A23403G  Europe=23 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1271.3" cy="619.1" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  A23403G  Europe=23 [100.0%] Asia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1271.3" cy="619.1" r="8.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  A23403G  Europe=23 [100.0%] Asia=3 [100.0%] North America=102 [99.0%]  surface glycoprotein, D614G</title>
	<circle cx="1271.3" cy="619.1" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  G23593T  North America=5 [4.9%]  surface glycoprotein, Q677H</title>
	<circle cx="1276.5" cy="577.1" r="3.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  C23604A  Europe=3 [13.0%]  surface glycoprotein, P681H</title>
	<circle cx="1276.8" cy="574.6" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  C23604A  North America=3 [2.9%]  surface glycoprotein, P681H</title>
	<circle cx="1276.8" cy="574.6" r="2.4" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  C23709T  Europe=4 [17.4%]  surface glycoprotein, T716I</title>
	<circle cx="1279.6" cy="551.4" r="5.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  G24095T  North America=4 [3.9%]  surface glycoprotein, A845S</title>
	<circle cx="1290.1" cy="466.1" r="2.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  C24099T  Europe=3 [13.0%]  surface glycoprotein, A846V</title>
	<circle cx="1290.2" cy="465.2" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  C24138T  North America=2 [1.9%]  surface glycoprotein, T859I</title>
	<circle cx="1291.3" cy="456.6" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  G24368A  North America=2 [1.9%]  surface glycoprotein, D936N</title>
	<circle cx="1297.5" cy="405.7" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  C24378T  North America=2 [1.9%]  surface glycoprotein, S939F</title>
	<circle cx="1297.8" cy="403.5" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  T24506G  Europe=3 [13.0%]  surface glycoprotein, S982A</title>
	<circle cx="1301.3" cy="375.2" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  C24912T  North America=2 [1.9%]  surface glycoprotein, T1117I</title>
	<circle cx="1312.3" cy="285.5" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  G24914C  Europe=3 [13.0%]  surface glycoprotein, D1118H</title>
	<circle cx="1312.3" cy="285.0" r="4.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  G25019T  North America=2 [1.9%]  surface glycoprotein, D1153Y</title>
	<circle cx="1315.2" cy="261.8" r="1.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-07  C25317T  Europe=2 [8.7%]  surface glycoprotein, S1252F</title>
	<circle cx="1323.3" cy="196.0" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-08 Europe: 28 samples</title>
	<line x1="1202.8" y1="1180.2" x2="1203.7" y2="1173.7" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-08 North America: 87 samples</title>
	<line x1="1203.7" y1="1173.7" x2="1204.9" y2="1165.0" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-08 Oceania: 3 samples</title>
	<line x1="1204.9" y1="1165.0" x2="1205.3" y2="1162.3" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-08 Asia: 2 samples</title>
	<line x1="1205.3" y1="1162.3" x2="1205.6" y2="1160.2" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-08 Africa: 2 samples</title>
	<line x1="1205.6" y1="1160.2" x2="1205.9" y2="1158.1" style="stroke:yellow;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-08  C21575T  North America=2 [2.3%]  surface glycoprotein, L5F</title>
	<circle cx="1224.8" cy="1023.6" r="2.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-08  G21600T  North America=8 [9.2%]  surface glycoprotein, S13I</title>
	<circle cx="1225.6" cy="1018.0" r="4.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-08  C21614T  Europe=13 [46.4%]  surface glycoprotein, L18F</title>
	<circle cx="1226.0" cy="1015.0" r="6.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-08  C21638T  North America=3 [3.4%]  surface glycoprotein, P26S</title>
	<circle cx="1226.7" cy="1009.7" r="2.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-08  C21855T  Europe=5 [17.9%]  surface glycoprotein, S98F</title>
	<circle cx="1233.5" cy="961.8" r="5.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-08  G21974T  North America=2 [2.3%]  surface glycoprotein, D138Y</title>
	<circle cx="1237.2" cy="935.6" r="2.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-08  G22018T  North America=8 [9.2%]  surface glycoprotein, W152C</title>
	<circle cx="1238.5" cy="925.9" r="4.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-08  C22227T  Africa=2 [100.0%]  surface glycoprotein, A222V</title>
	<circle cx="1245.0" cy="879.8" r="8.0" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-08  C22227T  Europe=18 [64.3%]  surface glycoprotein, A222V</title>
	<circle cx="1245.0" cy="879.8" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-08  G22335T  North America=3 [3.4%]  surface glycoprotein, W258L</title>
	<circle cx="1248.4" cy="855.9" r="2.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-08  T22917G  North America=7 [8.0%]  surface glycoprotein, L452R</title>
	<circle cx="1266.4" cy="727.6" r="3.8" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-08  A23403G  North America=87 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1281.5" cy="620.4" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-08  A23403G  North America=87 [100.0%] Europe=28 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1281.5" cy="620.4" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-08  A23403G  North America=87 [100.0%] Europe=28 [100.0%] Oceania=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1281.5" cy="620.4" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-08  A23403G  North America=87 [100.0%] Europe=28 [100.0%] Oceania=3 [100.0%] Asia=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1281.5" cy="620.4" r="8.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-08  A23403G  North America=87 [100.0%] Europe=28 [100.0%] Oceania=3 [100.0%] Asia=2 [100.0%] Africa=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1281.5" cy="620.4" r="8.0" style="fill:yellow;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-08  A23592C  North America=4 [4.6%]  surface glycoprotein, Q677P</title>
	<circle cx="1287.3" cy="578.7" r="3.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-08  C23604A  North America=6 [6.9%]  surface glycoprotein, P681H</title>
	<circle cx="1287.7" cy="576.1" r="3.6" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-08  G23868T  North America=2 [2.3%]  surface glycoprotein, G769V</title>
	<circle cx="1295.9" cy="517.8" r="2.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-08  C24099T  Europe=2 [7.1%]  surface glycoprotein, A846V</title>
	<circle cx="1303.0" cy="466.9" r="3.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-08  C25317T  Europe=3 [10.7%]  surface glycoprotein, S1252F</title>
	<circle cx="1340.8" cy="198.3" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-09 Europe: 23 samples</title>
	<line x1="1203.1" y1="1180.2" x2="1204.1" y2="1174.1" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-09 North America: 21 samples</title>
	<line x1="1204.1" y1="1174.1" x2="1205.0" y2="1168.1" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-09 Oceania: 3 samples</title>
	<line x1="1205.0" y1="1168.1" x2="1205.5" y2="1165.5" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-09 Asia: 6 samples</title>
	<line x1="1205.5" y1="1165.5" x2="1206.1" y2="1161.7" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-09  C21614T  Europe=6 [26.1%]  surface glycoprotein, L18F</title>
	<circle cx="1229.2" cy="1015.4" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-09  C21855T  Europe=5 [21.7%]  surface glycoprotein, S98F</title>
	<circle cx="1237.6" cy="962.4" r="5.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-09  C22088T  Europe=2 [8.7%]  surface glycoprotein, L176F</title>
	<circle cx="1245.7" cy="911.2" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-09  C22227T  Europe=16 [69.6%]  surface glycoprotein, A222V</title>
	<circle cx="1250.6" cy="880.6" r="7.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-09  A23403G  Europe=23 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1291.6" cy="621.9" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-09  A23403G  Europe=23 [100.0%] North America=21 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1291.6" cy="621.9" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-09  A23403G  Europe=23 [100.0%] North America=21 [100.0%] Asia=6 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1291.6" cy="621.9" r="8.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-09  A23403G  Europe=23 [100.0%] North America=21 [100.0%] Asia=6 [100.0%] Oceania=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1291.6" cy="621.9" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-09  G23593T  North America=2 [9.5%]  surface glycoprotein, Q677H</title>
	<circle cx="1298.2" cy="580.1" r="4.1" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-09  C23664T  Asia=2 [33.3%]  surface glycoprotein, A701V</title>
	<circle cx="1300.7" cy="564.5" r="6.1" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-09  C24099T  Europe=2 [8.7%]  surface glycoprotein, A846V</title>
	<circle cx="1315.8" cy="468.8" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-09  C24912T  Asia=2 [33.3%]  surface glycoprotein, T1117I</title>
	<circle cx="1344.1" cy="290.0" r="6.1" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-09  C25317T  Europe=2 [8.7%]  surface glycoprotein, S1252F</title>
	<circle cx="1358.2" cy="200.9" r="3.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-10 North America: 5 samples</title>
	<line x1="1203.5" y1="1180.3" x2="1204.1" y2="1176.9" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-10 Oceania: 4 samples</title>
	<line x1="1204.1" y1="1176.9" x2="1204.6" y2="1173.8" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-10 Asia: 4 samples</title>
	<line x1="1204.6" y1="1173.8" x2="1205.2" y2="1170.7" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-10  C22879A  Asia=3 [75.0%]  surface glycoprotein, N439K</title>
	<circle cx="1281.4" cy="738.5" r="7.5" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-10  A23403G  North America=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1301.6" cy="623.6" r="8.0" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-10  A23403G  North America=5 [100.0%] Oceania=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1301.6" cy="623.6" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-10  A23403G  North America=5 [100.0%] Oceania=4 [100.0%] Asia=4 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1301.6" cy="623.6" r="8.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-10  C23604G  Asia=3 [75.0%]  surface glycoprotein, P681R</title>
	<circle cx="1309.4" cy="579.5" r="7.5" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11 Europe: 825 samples</title>
	<line x1="1203.8" y1="1180.4" x2="1206.3" y2="1167.5" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-11 North America: 24 samples</title>
	<line x1="1206.3" y1="1167.5" x2="1207.5" y2="1161.3" style="stroke:fuchsia;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-11 Oceania: 2 samples</title>
	<line x1="1207.5" y1="1161.3" x2="1207.9" y2="1159.2" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-11  C21575T  North America=3 [12.5%]  surface glycoprotein, L5F</title>
	<circle cx="1234.0" cy="1025.1" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C21575T  Europe=18 [2.2%]  surface glycoprotein, L5F</title>
	<circle cx="1234.0" cy="1025.1" r="2.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  TT21576T  Europe=2 [0.2%]  surface glycoprotein, V6F</title>
	<circle cx="1234.0" cy="1024.9" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C21597T  Europe=5 [0.6%]  surface glycoprotein, S12F</title>
	<circle cx="1234.9" cy="1020.3" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G21600T  North America=3 [12.5%]  surface glycoprotein, S13I</title>
	<circle cx="1235.1" cy="1019.6" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C21614T  Europe=23 [2.8%]  surface glycoprotein, L18F</title>
	<circle cx="1235.7" cy="1016.6" r="2.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C21639A  Europe=3 [0.4%]  surface glycoprotein, P26H</title>
	<circle cx="1236.7" cy="1011.1" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C21707T  Europe=4 [0.5%]  surface glycoprotein, H49Y</title>
	<circle cx="1239.6" cy="996.2" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G21754T  Europe=4 [0.5%]  surface glycoprotein, W64C</title>
	<circle cx="1241.6" cy="986.0" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C21789T  Europe=2 [0.2%]  surface glycoprotein, T76I</title>
	<circle cx="1243.1" cy="978.3" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C21846T  North America=2 [8.3%]  surface glycoprotein, T95I</title>
	<circle cx="1245.5" cy="965.9" r="3.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C21855T  Europe=91 [11.0%]  surface glycoprotein, S98F</title>
	<circle cx="1245.9" cy="963.9" r="4.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C21855T  Europe=91 [11.0%] North America=2 [8.3%]  surface glycoprotein, S98F</title>
	<circle cx="1245.9" cy="963.9" r="3.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G21989T  Europe=26 [3.2%]  surface glycoprotein, V143F</title>
	<circle cx="1251.6" cy="934.6" r="2.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  ATTA21993A  Europe=40 [4.8%]  surface glycoprotein, Y145H</title>
	<circle cx="1251.8" cy="933.7" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G22018T  North America=3 [12.5%]  surface glycoprotein, W152C</title>
	<circle cx="1252.8" cy="928.2" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  ATTA22190A  Europe=4 [0.5%]  surface glycoprotein, I210N</title>
	<circle cx="1260.1" cy="890.6" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C22227T  Europe=427 [51.8%]  surface glycoprotein, A222V</title>
	<circle cx="1261.7" cy="882.6" r="6.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  A22259G  Europe=10 [1.2%]  surface glycoprotein, I233V</title>
	<circle cx="1263.1" cy="875.6" r="1.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  A22320G  North America=2 [8.3%]  surface glycoprotein, D253G</title>
	<circle cx="1265.7" cy="862.2" r="3.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G22343C  Europe=3 [0.4%]  surface glycoprotein, G261R</title>
	<circle cx="1266.6" cy="857.2" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G22346T  Europe=20 [2.4%]  surface glycoprotein, A262S</title>
	<circle cx="1266.8" cy="856.5" r="2.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C22350T  Europe=2 [0.2%]  surface glycoprotein, A263V</title>
	<circle cx="1266.9" cy="855.7" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C22377T  Europe=13 [1.6%]  surface glycoprotein, P272L</title>
	<circle cx="1268.1" cy="849.8" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C22879A  Europe=100 [12.1%]  surface glycoprotein, N439K</title>
	<circle cx="1289.4" cy="740.0" r="4.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  T22917G  North America=3 [12.5%]  surface glycoprotein, L452R</title>
	<circle cx="1291.0" cy="731.7" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C22986T  Europe=2 [0.2%]  surface glycoprotein, A475V</title>
	<circle cx="1294.0" cy="716.6" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G22992A  Europe=115 [13.9%]  surface glycoprotein, S477N</title>
	<circle cx="1294.2" cy="715.3" r="4.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C22993G  Europe=2 [0.2%]  surface glycoprotein, S477R</title>
	<circle cx="1294.3" cy="715.1" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G23012A  North America=2 [8.3%]  surface glycoprotein, E484K</title>
	<circle cx="1295.1" cy="710.9" r="3.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  A23063T  Europe=38 [4.6%]  surface glycoprotein, N501Y</title>
	<circle cx="1297.2" cy="699.8" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  A23064C  North America=3 [12.5%]  surface glycoprotein, N501T</title>
	<circle cx="1297.3" cy="699.6" r="4.5" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C23271A  Europe=38 [4.6%]  surface glycoprotein, A570D</title>
	<circle cx="1306.1" cy="654.3" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  A23403G  Oceania=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1311.7" cy="625.5" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  A23403G  Oceania=2 [100.0%] Europe=824 [99.9%]  surface glycoprotein, D614G</title>
	<circle cx="1311.7" cy="625.5" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  A23403G  Oceania=2 [100.0%] Europe=824 [99.9%] North America=23 [95.8%]  surface glycoprotein, D614G</title>
	<circle cx="1311.7" cy="625.5" r="7.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C23481T  North America=2 [8.3%]  surface glycoprotein, S640F</title>
	<circle cx="1315.0" cy="608.4" r="3.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C23481T  Europe=10 [1.2%]  surface glycoprotein, S640F</title>
	<circle cx="1315.0" cy="608.4" r="1.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G23501T  Europe=2 [0.2%]  surface glycoprotein, A647S</title>
	<circle cx="1315.8" cy="604.0" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G23564T  Europe=3 [0.4%]  surface glycoprotein, A668S</title>
	<circle cx="1318.5" cy="590.3" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  A23579G  Europe=7 [0.8%]  surface glycoprotein, S673G</title>
	<circle cx="1319.2" cy="587.0" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G23580C  Europe=2 [0.2%]  surface glycoprotein, S673T</title>
	<circle cx="1319.2" cy="586.8" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G23587T  Europe=2 [0.2%]  surface glycoprotein, Q675H</title>
	<circle cx="1319.5" cy="585.2" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G23593T  Europe=9 [1.1%]  surface glycoprotein, Q677H</title>
	<circle cx="1319.8" cy="583.9" r="1.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  T23599A  Europe=2 [0.2%]  surface glycoprotein, N679K</title>
	<circle cx="1320.0" cy="582.6" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C23604A  North America=2 [8.3%]  surface glycoprotein, P681H</title>
	<circle cx="1320.2" cy="581.5" r="3.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C23604A  North America=2 [8.3%] Europe=44 [5.3%]  surface glycoprotein, P681H</title>
	<circle cx="1320.2" cy="581.5" r="3.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C23604G  Europe=3 [0.4%]  surface glycoprotein, P681R</title>
	<circle cx="1320.2" cy="581.5" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C23664T  North America=2 [8.3%]  surface glycoprotein, A701V</title>
	<circle cx="1322.8" cy="568.4" r="3.9" style="fill:fuchsia;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C23709T  Europe=41 [5.0%]  surface glycoprotein, T716I</title>
	<circle cx="1324.7" cy="558.6" r="3.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  A23780C  Europe=6 [0.7%]  surface glycoprotein, M740L</title>
	<circle cx="1327.7" cy="543.0" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C23987T  Europe=4 [0.5%]  surface glycoprotein, P809S</title>
	<circle cx="1336.5" cy="497.8" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G24000T  Europe=5 [0.6%]  surface glycoprotein, S813I</title>
	<circle cx="1337.1" cy="494.9" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C24099T  Europe=10 [1.2%]  surface glycoprotein, A846V</title>
	<circle cx="1341.3" cy="473.3" r="1.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C24138T  Europe=6 [0.7%]  surface glycoprotein, T859I</title>
	<circle cx="1342.9" cy="464.8" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G24257T  Europe=5 [0.6%]  surface glycoprotein, A899S</title>
	<circle cx="1348.0" cy="438.7" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C24378T  Europe=12 [1.5%]  surface glycoprotein, S939F</title>
	<circle cx="1353.1" cy="412.3" r="1.6" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  A24402G  Europe=7 [0.8%]  surface glycoprotein, K947R</title>
	<circle cx="1354.1" cy="407.0" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  T24506G  Europe=38 [4.6%]  surface glycoprotein, S982A</title>
	<circle cx="1358.6" cy="384.3" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G24620T  Europe=6 [0.7%]  surface glycoprotein, A1020S</title>
	<circle cx="1363.4" cy="359.4" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G24764C  Europe=2 [0.2%]  surface glycoprotein, V1068L</title>
	<circle cx="1369.5" cy="327.9" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  A24780C  Europe=24 [2.9%]  surface glycoprotein, K1073T</title>
	<circle cx="1370.2" cy="324.4" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G24794T  Europe=15 [1.8%]  surface glycoprotein, A1078S</title>
	<circle cx="1370.8" cy="321.3" r="1.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  T24814A  Europe=5 [0.6%]  surface glycoprotein, D1084E</title>
	<circle cx="1371.6" cy="317.0" r="0.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G24914C  Europe=38 [4.6%]  surface glycoprotein, D1118H</title>
	<circle cx="1375.9" cy="295.1" r="3.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G24926T  Europe=3 [0.4%]  surface glycoprotein, V1122L</title>
	<circle cx="1376.4" cy="292.5" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C25046T  Europe=6 [0.7%]  surface glycoprotein, P1162S</title>
	<circle cx="1381.5" cy="266.3" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C25047T  Europe=2 [0.2%]  surface glycoprotein, P1162L</title>
	<circle cx="1381.5" cy="266.0" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G25049T  Europe=4 [0.5%]  surface glycoprotein, D1163Y</title>
	<circle cx="1381.6" cy="265.6" r="0.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G25157T  Europe=2 [0.2%]  surface glycoprotein, D1199Y</title>
	<circle cx="1386.2" cy="242.0" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G25166C  Europe=7 [0.8%]  surface glycoprotein, E1202Q</title>
	<circle cx="1386.6" cy="240.0" r="1.1" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G25217T  Europe=25 [3.0%]  surface glycoprotein, G1219C</title>
	<circle cx="1388.8" cy="228.9" r="2.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G25218T  Europe=3 [0.4%]  surface glycoprotein, G1219V</title>
	<circle cx="1388.8" cy="228.6" r="0.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G25352T  Europe=2 [0.2%]  surface glycoprotein, V1264L</title>
	<circle cx="1394.5" cy="199.4" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  A25450G  Europe=52 [6.3%]  ORF3a protein, I20V</title>
	<circle cx="1398.7" cy="177.9" r="3.5" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C25460T  Europe=2 [0.2%]  ORF3a protein, A23V</title>
	<circle cx="1399.1" cy="175.7" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  C25469T  Europe=2 [0.2%]  ORF3a protein, S26L</title>
	<circle cx="1399.5" cy="173.8" r="0.4" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G25471T  Europe=8 [1.0%]  ORF3a protein, D27Y</title>
	<circle cx="1399.6" cy="173.3" r="1.2" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-11  G25481T  Europe=6 [0.7%]  ORF3a protein, R30L</title>
	<circle cx="1400.0" cy="171.1" r="0.9" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-12 Europe: 8 samples</title>
	<line x1="1204.2" y1="1180.4" x2="1205.1" y2="1176.2" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-12 Asia: 3 samples</title>
	<line x1="1205.1" y1="1176.2" x2="1205.6" y2="1173.6" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-12  C21855T  Europe=4 [50.0%]  surface glycoprotein, S98F</title>
	<circle cx="1250.0" cy="964.7" r="6.8" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-12  G23012A  Asia=2 [66.7%]  surface glycoprotein, E484K</title>
	<circle cx="1303.6" cy="712.7" r="7.3" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-12  A23063T  Europe=3 [37.5%]  surface glycoprotein, N501Y</title>
	<circle cx="1305.9" cy="701.6" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-12  C23271A  Europe=3 [37.5%]  surface glycoprotein, A570D</title>
	<circle cx="1315.6" cy="656.2" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-12  A23403G  Europe=8 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1321.7" cy="627.5" r="8.0" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-12  A23403G  Europe=8 [100.0%] Asia=3 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1321.7" cy="627.5" r="8.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-12  C23604A  Europe=3 [37.5%]  surface glycoprotein, P681H</title>
	<circle cx="1331.0" cy="583.7" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-12  C23709T  Europe=3 [37.5%]  surface glycoprotein, T716I</title>
	<circle cx="1335.9" cy="560.8" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-12  C24099T  Europe=2 [25.0%]  surface glycoprotein, A846V</title>
	<circle cx="1353.9" cy="475.9" r="5.7" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-12  T24506G  Europe=3 [37.5%]  surface glycoprotein, S982A</title>
	<circle cx="1372.8" cy="387.2" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-12  G24914C  Europe=3 [37.5%]  surface glycoprotein, D1118H</title>
	<circle cx="1391.7" cy="298.3" r="6.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-13 Europe: 3 samples</title>
	<line x1="1204.5" y1="1180.5" x2="1205.1" y2="1177.9" style="stroke:cyan;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-13 Asia: 5 samples</title>
	<line x1="1205.1" y1="1177.9" x2="1205.9" y2="1174.5" style="stroke:orange;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-13  A23403G  Asia=5 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1331.7" cy="629.7" r="8.0" style="fill:orange;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-13  A23403G  Europe=2 [66.7%]  surface glycoprotein, D614G</title>
	<circle cx="1331.7" cy="629.7" r="7.3" style="fill:cyan;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<g>
	<title>2021-01-15 Oceania: 2 samples</title>
	<line x1="1205.2" y1="1180.7" x2="1205.7" y2="1178.6" style="stroke:white;stroke-width:0.8;stroke-opacity:50%;" />
</g>
<g>
	<title>2021-01-15  A23403G  Oceania=2 [100.0%]  surface glycoprotein, D614G</title>
	<circle cx="1351.5" cy="634.6" r="8.0" style="fill:white;stroke:black;stroke-width:0;fill-opacity:0.25;"/>
</g>
<rect x="1865" y="140" width="500" height="135" rx="15" style="fill:gainsboro;stroke-width:0;fill-opacity:0.15;" />
<text font-size="1.8em" x="1880" y="170" fill="white">Data from 6 continents</text>
<text font-size="1.8em" x="1880" y="200" fill="white">Genomes/year≥10  Genomes/day≥2</text>
<text font-size="1.8em" x="1880" y="230" fill="white">186 distinct missense variants mapped</text>
<text font-size="1.8em" x="1880" y="260" fill="white">Updated 2021-01-21</text>
</svg>
